参考文献/References:
[1] Cooney LG,Lee I,Sammel MD,et al.High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome:a systematic review and metaanalysis[J].Human Reproduction,2017,32(5):10751091.
[2] Pakrashi T,Baydoun H,Bocca S,et al.Luteal phase supplementation with vaginal progesterone in women with polycystic ovary syndrome and ovulatory dysfunction undergoing ovulation induction with letrozole:a randomized controlled trial[J].Fertility & Sterility,2014,102(3):237.
[3] Geisthovel F.A comment on the european society of human reproduction and embryology/american society for reproductive medicine consensus of the polycystic ovarian syndrome[J].Reproductive Biomedicine Online,2003,7(6):602605.
[4] 李文静,胡红波,马占忠,等.韶关地区育龄妇女多囊卵巢综合征患病状况流行病学调查研究[J].黑龙江医学,2016,40(7):646648.
[5] 王亚丛,喻麟琳,王 丽,等.多囊卵巢综合征患者早期妊娠自然流产的预防[J].医学信息,2014,7(21):147148.
[6] 唐蓉辉,汤惠茹,王丽平,等.深圳市汉族育龄妇女多囊卵巢综合症患病率及临床特征分析[J].罕少疾病杂志,2010,17(1):15.
[7] 张海军.3种不同促排卵治疗方案对多囊卵巢综合征促排卵的疗效分析[J].中国妇幼保健,2018,33(1):156158.
[8] 南 燕,田燕妮.复方玄驹胶囊联合达英35、克罗米芬治疗多囊卵巢综合征临床研究[J].陕西中医,2017,38(4):448449.
[9] 王仕丽,陈 涛,刘跃辉,等.克罗米芬联合尿促性素对多囊卵巢综合症患者促排卵效果及其对妊娠的影响研究[J].药学与临床研究,2015,9(4):383387.
[10] Franik S,Kremer JA,Nelen WL,et al.Aromatase inhibitors for subfertile women with polycystic ovary syndrome[J].Fertility & Sterility,2014,2(2):353355.
[11] 张亦心.尿黄体生成素半定量试纸检测结合超声监测卵泡在预测排卵中的临床应用价值[J].中国妇幼保健,2015,33(14):32553258.
[12] 张云霞.经阴道超声监测卵泡发育在不孕患者中的应用[J].陕西医学杂志,2016,45(8):10421043.
[13] 丁 波,袁 丽,孙文兵,等.经阴道超声监测卵泡发育在不孕患者中应用的价值研究[J].中国性科学,2018,27(1):9294.
[14] 胡 英,李 娟,符免艾,等.人工授精联合卵泡穿刺术治疗未破裂卵泡黄素化不孕中的应用[J].中国性科学,2017,26(7):133135.
[15] 胡艳梅,伍文霞,徐永莲.不同促排卵方案对高黄体生成素(LH)多囊卵巢综合征(PCOS)不孕患者妊娠结局的对比分析[J].中国优生与遗传杂志,2018,26(5):123126.
[16] 王沛丽,王 芳,丁 楠.来曲唑和克罗米芬分别联合HMG治疗多囊卵巢综合征疗效的系统评价[J].生殖医学杂志,2015,24(8):626633.
相似文献/References:
[1]王钰,李小燕,宋民喜,等.不同表型多囊卵巢综合征患者甲状腺功能改变及临床意义[J].陕西医学杂志,2016,(10):1303.
[2]胡瑞杰,宋民喜,徐 琳,等.吡格列酮二甲双胍对多囊卵巢综合征不孕患者糖脂代谢及妊娠率的影响[J].陕西医学杂志,2021,50(2):221.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.024]
HU Ruijie,SONG Minxi,XU Lin,et al.Effect of pioglitazone and metformin on glucose-lipid metabolism and pregnancy rate in treating infertile patients with PCOS[J].,2021,50(1):221.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.024]
[3]李 婷,李雪倩,尹东升.多囊卵巢综合征患者妊娠期体内维生素D水平与血脂代谢以及妊娠结局的关系[J].陕西医学杂志,2022,51(1):55.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.014]
LI Ting,LI Xueqian,YIN Dongsheng.Relationship between vitamin D level and blood lipid metabolism,pregnancy outcome in patients with polycystic ovary syndrome during gestational period[J].,2022,51(1):55.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.014]
[4]崔荣荣,王晨鸽,尹东升.来曲唑联合克罗米芬治疗多囊卵巢综合征疗效观察[J].陕西医学杂志,2022,51(3):359.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.022]
[5]钟社兰,陈 星.多囊卵巢综合征与失眠症共病患者临床特征及相关因素分析[J].陕西医学杂志,2023,52(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.016]
ZHONG Shelan,CHEN Xing.Clinical characteristics and related factors of insomnia in patients with polycystic ovary syndrome[J].,2023,52(1):437.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.016]
[6]郑锦霞,刘智慧,孙 燕,等.多囊卵巢综合征不孕患者血清促肾上腺皮质激素、抗苗勒管激素、胰岛素抵抗水平与负性情绪、生活质量相关性研究[J].陕西医学杂志,2023,52(10):1340.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.012]
ZHENG Jinxia,LIU Zhihui,SUN Yan,et al.Correlation between serum levels of adrenocorticotropic hormone,anti-Mullerian hormone,insulin resistance and negative emotions,quality of life in infertile patients with polycystic ovary syndrome[J].,2023,52(1):1340.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.012]
[7]何静子,穆其琛,付东阁,等.lncRNA TMPO-AS1通过PI3K/Akt信号通路对多囊卵巢综合征大鼠性激素和卵巢功能的影响[J].陕西医学杂志,2024,(2):152.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.002]
HE Jingzi,MU Qichen,FU Dongge,et al.Effect of lncRNA TMPO-AS1 on sex hormones and ovarian function in rats with polycystic ovary syndrome through PI3K/Akt signaling pathway[J].,2024,(1):152.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.002]
[8]杨加宁,张立然.沉默信息调节因子1/叉头框蛋白O1信号通路调控铁死亡对多囊卵巢综合征大鼠卵巢颗粒细胞的影响实验研究[J].陕西医学杂志,2024,(8):1035.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.006]
YANG Jianing,ZHANG Liran.Effect of silent information regulator 1/forkhead box protein O1 signaling pathway on ovarian granulosa cells in rats with polycystic ovary syndrome by regulating ferroptosis[J].,2024,(1):1035.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.006]